Evidence map›Paper›PMID 25887612›Full record

ReviewCurrent opinion in infectious diseases2015

I can see CRISPR now, even when phage are gone: a view on alternative CRISPR-Cas functions from the prokaryotic envelope.

Hannah K Ratner, Timothy R Sampson, David S Weiss

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. CRISPR/Cas System and Factors Affecting Its Precision and Efficiency.Frontiers in cell and developmental biology · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Aquaculture as a source of empirical evidence for coevolution between CRISPR-Cas and phage.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Review
  17. Review
  18. Frontiers in genetics · 2018
    Article
  19. Article
  20. Overview of CRISPR-Cas9 Biology.Cold Spring Harbor protocols · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Hannah K RatneraDepartment of Microbiology and Immunology, Microbiology and Molecular Genetics Program bEmory Vaccine Center cYerkes National Primate Research Center, Atlanta, Georgia dDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California eDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA *Hannah K. Ratner and Dr Timothy R. Sampson contributed equally to the writing of this article.
Timothy R Sampson
David S Weiss
California Institute of Technology · USEmory National Primate Research CenterEmory University · US

Funding

CRISPR/Cas systems in bacterial gene regulation and virulenceR01AI110701 · NIAID · EMORY UNIVERSITY · PI WEISS, DAVID S · 2014 to 2018
$2.2M
NIAID NIH HHS R01 AI110701NIAID NIH HHS R01-AI110701
6 · The paper itself

Abstract

purpose of reviewCRISPR-Cas systems are prokaryotic immune systems against invading nucleic acids that adapt as new environmental threats arise. There are emerging examples of CRISPR-Cas functions in bacterial physiology beyond their role in adaptive immunity. This highlights the poorly understood, but potentially common, moonlighting functions of these abundant systems. We propose that these noncanonical CRISPR-Cas activities have evolved to respond to stresses at the cell envelope. RECENT

findingsHere, we discuss recent literature describing the impact of the extracellular environment on the regulation of CRISPR-Cas systems, and the influence of CRISPR-Cas activity on bacterial physiology. These described noncanonical CRISPR-Cas functions allow the bacterial cell to respond to the extracellular environment, primarily through changes in envelope physiology. SUMMARY: This review discusses the expanding noncanonical functions of CRISPR-Cas systems, including their roles in virulence, focusing mainly on their relationship to the cell envelope. We first examine the effects of the extracellular environment on regulation of CRISPR-Cas components, and then discuss the impact of CRISPR-Cas systems on bacterial physiology, concentrating on their roles in influencing interactions with the environment including host organisms.

Indexed as

Adaptive ImmunityAntibodies, ViralBacterial InfectionsCRISPR-Cas SystemsHost-Pathogen InteractionsHumansPhylogenyViral Envelope ProteinsAntibodies, ViralViral Envelope Proteins

Identifiers

PMID25887612
PMCPMC4414917
OpenAlexW2017952200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.